HOME >> MEDICINE >> NEWS
FDA approves prescription Zaditor for over-the-counter relief from itchy eyes

Florham Park, NJ, October 20, 2006 -- Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved prescription Zaditor (ketotifen fumarate ophthalmic solution 0.025%), indicated for the temporary prevention of itchy eyes due to allergic conjunctivitis, for OTC use. An estimated 40 million Americans suffer from eye allergies. Whether in reaction to seasonal allergens including pollen and ragweed, or perennial allergens such as animal hair or pet dander, itchy eyes are a main complaint.

While most OTC products provide only 3-4 hours of short-term relief, Zaditor's full prescription strength formula offers eye itch relief that works in minutes and lasts up to 12 hours with just one drop. This significantly reduces the number of doses required per day to keep affected eyes itch-free. In addition, Zaditor is the first OTC eye itch medication safe for use in children as young as three.

"Now for the first time, people who suffer from itchy eyes caused by allergens such as pollen or pet dander can get fast, long-acting relief over-the-counter with Zaditor," says Marion Morton, Head of the US Novartis Ophthalmics Business Unit. "Because Zaditor is now available at full prescription strength without a prescription, consumers can save time and money without sacrificing long-lasting symptom relief."

Zaditor is the only OTC drop to treat eye itch associated with pollen, ragweed, grass, animal hair and dander without the potentially negative effects of a decongestant. Many OTC eye drops contain topical decongestants, which constrict the blood vessels to reduce the appearance of redness in the eye. With regular use, these products can interfere with the eye's natural ability to regulate the blood vessels, resulting in a continued redness for a period of time after discontinuation (rebound effect). Zaditor does not contain a decongestant and may be used without risk of rebound redness.

<
'"/>

Contact: Beth Rowan
rowanb@ruderfinn.com
212-583-2780
Ruder Finn Public Relations
20-Oct-2006


Page: 1 2

Related medicine news :

1. DFG approves 11 new Collaborative Research Centers
2. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
3. FDA approves Dey, L.P.s Perforomist inhalation solution for maintenance treatment of COPD
4. VCR -- FDA approves home discharge for US patients
5. FDA approves Vectibix to treat patients with metastatic colorectal cancer
6. 5,000 rare diseases need drugs, but Europe only approves a handful each year
7. FDA approves room temperature storage of ZLB Behrings Helixate FS
8. FDA approves new indication for Topamax as initial monotherapy for adults and children with epilepsy
9. FDA approves first blood test to predict risk for stroke
10. FDA approves Boostrix a new US vaccine for adolescents against pertussis
11. Controlling prescription drug expenditures: a case report of success

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2020)... (PRWEB) , ... March 27, 2020 , ... On March ... educational health conference for people with asthma, their families and caregivers living in the ... between March 27, 2020 and June 30, 2020, and will focus on asthma symptoms, ...
(Date:3/27/2020)... ... ... During a time of global distress and concern about the impact of COVID-19, T1 ... Education and Support Fund in an effort to assist hospitality workers whose jobs have ... working people in the food service , hotel and other major industries ...
(Date:3/22/2020)... ... March 21, 2020 , ... In partnership with UC Health, ... our community’s medical professionals and first responders. The title comes from the English translation ... city and its flag. , Proceeds from the sale of the shirt will ...
(Date:3/22/2020)... , ... March 22, 2020 , ... “At a time ... do not feel well, Preferred Health Insurance Solutions’ First Stop Health Telemedicine program ... flu season underway, First Stop Health Telemedicine program, is a valuable tool that can ...
(Date:3/20/2020)... ... 20, 2020 , ... My heart goes out to those across our nation ... a loved one recently through similar circumstances - underlying conditions compounded by a virus ... a gamut of negative emotions just like many have: fear, anxiety, uncertainty. In contrast, ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... ... April 02, 2020 , ... Planning an Audit Response:, ... Despite best efforts to the contrary, having nonconformities spotted by a notified body during ... will be under a strict deadline and under pressure with only 15 days to ...
(Date:4/1/2020)... (PRWEB) , ... April 01, 2020 , ... Care Station ... Medical Group has implemented a number of changes to better care for our community. ... updated our office hours and crafted new ways to offer medical care to patients ...
(Date:3/30/2020)... ... 30, 2020 , ... CPSI (NASDAQ: CPSI), a ... By leveraging technology developed by its wholly owned subsidiary, Get Real Health® ... services while serving patients’ needs during the COVID-19 outbreak. , TalkWithYourDoc.com, ...
Breaking Medicine Technology:
Cached News: